Web Stats Provided By Google Analytics

Wednesday, September 24, 2014

On eve of IPO, Civitas Therapeutics is acquired for $525

On the eve of a planned $75 initial public offering, Chelsea biotech firm Civitas Therapeutics has been acquired by an Ardsley, NY-based biotech for $525 million.

http://ift.tt/1mRCiou

No comments:

Post a Comment

Popular Ardsley Roundup Posts